Studies on Potential Antiviral Compounds, XXIV. New 1‐substituted isatin β‐thiosemicarbazones

Anna Ferranti*, Laura Garuti, Giuseppe Giovanninetti, Ehud Katz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Some new 1‐substituted isatin β‐thiosemicarbazones were examined for their ability to inhibit the growth of the wild‐type strain of vaccinia virus and the isatin P‐thiosemicarbazone (IBT) resistant mutant of this virus. Also investigated was the capability of the compounds to support the growth of the IBT dependent mutant of vaccinia virus. The most active derivative is 1‐(3‐hydroxypropyl)isatin thiosemicarbazone 20, which was shown to be more effective than IBT.

Original languageEnglish
Pages (from-to)415-421
Number of pages7
JournalArchiv der Pharmazie
Volume318
Issue number5
DOIs
StatePublished - 1985

Fingerprint

Dive into the research topics of 'Studies on Potential Antiviral Compounds, XXIV. New 1‐substituted isatin β‐thiosemicarbazones'. Together they form a unique fingerprint.

Cite this